Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

3D printed PLGA implants: APF DDM vs. FDM.

Bassand, C, Benabed, L, Charlon, S, Verin, J, Freitag, J, Siepmann, F, Soulestin, J and Siepmann, J (2022) 3D printed PLGA implants: APF DDM vs. FDM. Journal of controlled release : official journal of the Controlled Release Society. ISSN 1873-4995

Abstract

3D Printing offers a considerable potential for personalized medicines. This is especially true for customized biodegradable implants, matching the specific needs of each patient. Poly(lactic-co-glycolic acid) (PLGA) is frequently used as matrix former in biodegradable implants. However, yet relatively little is known on the technologies, which can be used for the 3D printing of PLGA implants. The aim of this study was to compare: (i) Arburg Plastic Freeforming Droplet Deposition Modeling (APF DDM), and (ii) Fused Deposition Modeling (FDM) to print mesh-shaped, ibuprofen-loaded PLGA implants. During APF DDM, individual drug-polymer droplets are deposited, fusing together to form filaments, which build up the implants. During FDM, continuous drug-polymer filaments are deposited to form the meshes. The implants were thoroughly characterized before and after exposure to phosphate buffer pH 7.4 using optical and scanning electron microscopy, GPC, DSC, drug release measurements and monitoring dynamic changes in the systems' dry & wet mass and pH of the bulk fluid. Interestingly, the mesh structures were significantly differed, although the device design (composition & theoretical geometry) were the same. This could be explained by the fact that the deposition of individual droplets during APF DDM led to curved and rather thick filaments, resulting in a much lower mesh porosity. In contrast, FDM printing generated straight and thinner filaments: The open spaces between them were much larger and allowed convective mass transport during drug release. Consequently, most of the drug was already released after 4 d, when substantial PLGA set on. In the case of APF DDM printed implants, most of the drug was still entrapped at that time point and substantial polymer swelling transformed the meshes into more or less continuous PLGA gels. Hence, the diffusion pathways became much longer and ibuprofen release was controlled over 2 weeks.

Item Type: Article
Date Deposited: 20 Dec 2022 00:45
Last Modified: 20 Dec 2022 00:45
URI: https://oak.novartis.com/id/eprint/49211

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.